REFERENCES
1. Delling JP, Boeckers TM. Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications. J Neurodev Disord 2021;13:55.
2. Böckers TM, Mameza MG, Kreutz MR, et al. Synaptic scaffolding proteins in rat brain: ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein alpha-fodrin. J Biol Chem 2001;276:40104-12.
3. Sala C, Piëch V, Wilson NR, Passafaro M, Liu G, Sheng M. Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 2001;31:115-30.
4. Gundelfinger ED, Boeckers TM, Baron MK, Bowie JU. A role for zinc in postsynaptic density asSAMbly and plasticity? Trends Biochem Sci 2006;31:366-73.
5. Liebau S, Proepper C, Schmidt T, Schoen M, Bockmann J, Boeckers TM. ProSAPiP2, a novel postsynaptic density protein that interacts with ProSAP2/Shank3. Biochem Biophys Res Commun 2009;385:460-5.
6. Haeckel A, Ahuja R, Gundelfinger ED, Qualmann B, Kessels MM. The actin-binding protein Abp1 controls dendritic spine morphology and is important for spine head and synapse formation. J Neurosci 2008;28:10031-44.
7. Arons MH, Lee K, Thynne CJ, et al. Shank3 is part of a zinc-sensitive signaling system that regulates excitatory synaptic strength. J Neurosci 2016;36:9124-34.
8. Sarowar T, Grabrucker AM. Actin-dependent alterations of dendritic spine morphology in shankopathies. Neural Plast 2016;2016:8051861.
9. Lim S, Naisbitt S, Yoon J, et al. Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development. J Biol Chem 1999;274:29510-8.
10. Wang X, McCoy PA, Rodriguiz RM, et al. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet 2011;20:3093-108.
11. Zhu L, Wang X, Li XL, et al. Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders. Hum Mol Genet 2014;23:1563-78.
12. Monteiro P, Feng G. SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat Rev Neurosci 2017;18:147-57.
13. Waga C, Asano H, Sanagi T, et al. Identification of two novel Shank3 transcripts in the developing mouse neocortex. J Neurochem 2014;128:280-93.
14. Wang X, Xu Q, Bey AL, Lee Y, Jiang Y. Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant mice. Mol Autism 2014;5:30.
15. Bouquier N, Sakkaki S, Raynaud F, et al. The Shank3Venus/Venus knock in mouse enables isoform-specific functional studies of Shank3a. Front Neurosci 2022;16:1081010.
16. Kim Y, Ko TH, Jin C, et al. The emerging roles of Shank3 in cardiac function and dysfunction. Front Cell Dev Biol 2023;11:1191369.
17. Wilson HL, Wong ACC, Shaw SR, et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 2003;40:575-84.
18. Jin C, Kang HR, Kang H, et al. Unexpected compensatory increase in Shank3 transcripts in Shank3 knock-out mice having partial deletions of exons. Front Mol Neurosci 2019;12:228.
19. Naisbitt S, Kim E, Tu JC, et al. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 1999;23:569-82.
20. Malara M, Lutz AK, Incearap B, et al. SHANK3 deficiency leads to myelin defects in the central and peripheral nervous system. Cell Mol Life Sci 2022;79:371.
21. Lutz AK, Pfaender S, Incearap B, et al. Autism-associated SHANK3 mutations impair maturation of neuromuscular junctions and striated muscles. Sci Transl Med 2020;12:eaaz3267.
22. Sauer AK, Bockmann J, Steinestel K, Boeckers TM, Grabrucker AM. Altered Intestinal morphology and microbiota composition in the autism spectrum disorders associated SHANK3 mouse model. Int J Mol Sci 2019;20:2134.
23. Wei SC, Yang-Yen HF, Tsao PN, et al. SHANK3 regulates intestinal barrier function through modulating ZO-1 expression through the PKCε-dependent pathway. Inflamm Bowel Dis 2017;23:1730-40.
24. Grabrucker S, Proepper C, Mangus K, et al. The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation. Exp Neurol 2014;253:126-37.
25. Leblond CS, Nava C, Polge A, et al. Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments. PLoS Genet 2014;10:e1004580.
26. Misceo D, Rødningen OK, Barøy T, et al. A translocation between Xq21.33 and 22q13.33 causes an intragenic SHANK3 deletion in a woman with Phelan-McDermid syndrome and hypergonadotropic hypogonadism. Am J Med Genet A 2011;155:403-8.
27. Sarasua SM, Dwivedi A, Boccuto L, et al. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome). J Med Genet 2011;48:761-6.
28. Luciani JJ, de Mas P, Depetris D, et al. Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: cytogenetic, molecular, and clinical analyses of 32 new observations. J Med Genet 2003;40:690-6.
29. Samogy-Costa CI, Varella-Branco E, Monfardini F, et al. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case. J Neurodev Disord 2019;11:13.
30. Xu N, Lv H, Yang T, et al. A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes. Orphanet J Rare Dis 2020;15:335.
31. Liu C, Li D, Yang H, et al. Altered striatum centered brain structures in SHANK3 deficient Chinese children with genotype and phenotype profiling. Prog Neurobiol 2021;200:101985.
32. Wegiel J, Flory M, Kuchna I, et al. Neuronal nucleus and cytoplasm volume deficit in children with autism and volume increase in adolescents and adults. Acta Neuropathol Commun 2015;3:2.
33. Wegiel J, Flory M, Kuchna I, et al. Brain-region-specific alterations of the trajectories of neuronal volume growth throughout the lifespan in autism. Acta Neuropathol Commun 2014;2:28.
34. Wu S, Gan G, Zhang Z, et al. A presynaptic function of shank protein in Drosophila. J Neurosci 2017;37:11592-604.
35. Harris KP, Akbergenova Y, Cho RW, Baas-Thomas MS, Littleton JT. Shank modulates postsynaptic wnt signaling to regulate synaptic development. J Neurosci 2016;36:5820-32.
36. Liu CX, Li CY, Hu CC, et al. CRISPR/Cas9-induced shank3b mutant zebrafish display autism-like behaviors. Mol Autism 2018;9:23.
37. Liu C, Wang Y, Deng J, et al. Social deficits and repetitive behaviors are improved by early postnatal low-dose VPA intervention in a novel shank3-deficient zebrafish model. Front Neurosci 2021;15:682054.
38. Kozol RA, James DM, Varela I, Sumathipala SH, Züchner S, Dallman JE. Restoring Shank3 in the rostral brainstem of shank3ab-/- zebrafish autism models rescues sensory deficits. Commun Biol 2021;4:1411.
39. Kareklas K, Teles MC, Dreosti E, Oliveira RF. Autism-associated gene shank3 is necessary for social contagion in zebrafish. Mol Autism 2023;14:23.
40. Kouser M, Speed HE, Dewey CM, et al. Loss of predominant Shank3 isoforms results in hippocampus-dependent impairments in behavior and synaptic transmission. J Neurosci 2013;33:18448-68.
41. Lee J, Chung C, Ha S, et al. Shank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit. Front Cell Neurosci 2015;9:94.
42. Zhou Y, Kaiser T, Monteiro P, et al. Mice with Shank3 mutations associated with ASD and schizophrenia display both shared and distinct defects. Neuron 2016;89:147-62.
43. Speed HE, Kouser M, Xuan Z, et al. Autism-associated insertion mutation (InsG) of Shank3 exon 21 causes impaired synaptic transmission and behavioral deficits. J Neurosci 2015;35:9648-65.
44. Wang X, Bey AL, Katz BM, et al. Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism. Nat Commun 2016;7:11459.
45. Harony-Nicolas H, Kay M, du Hoffmann J, et al. Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat. Elife 2017;6:e18904.
46. Song TJ, Lan XY, Wei MP, et al. Altered behaviors and impaired synaptic function in a novel rat model with a complete Shank3 deletion. Front Cell Neurosci 2019;13:111.
47. Jennings CG, Landman R, Zhou Y, et al. Opportunities and challenges in modeling human brain disorders in transgenic primates. Nat Neurosci 2016;19:1123-30.
49. Bozdagi O, Sakurai T, Papapetrou D, et al. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol Autism 2010;1:15.
50. Peça J, Feliciano C, Ting JT, et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011;472:437-42.
51. Zhao H, Tu Z, Xu H, et al. Altered neurogenesis and disrupted expression of synaptic proteins in prefrontal cortex of SHANK3-deficient non-human primate. Cell Res 2017;27:1293-7.
52. Zhou Y, Sharma J, Ke Q, et al. Atypical behaviour and connectivity in SHANK3-mutant macaques. Nature 2019;570:326-31.
53. Bauman MD, Schumann CM. Advances in nonhuman primate models of autism: integrating neuroscience and behavior. Exp Neurol 2018;299:252-65.
54. Izpisua Belmonte JC, Callaway EM, Caddick SJ, et al. Brains, genes, and primates. Neuron 2015;86:617-31.
55. Liu Z, Li X, Zhang JT, et al. Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2. Nature 2016;530:98-102.
56. Chen Y, Yu J, Niu Y, et al. Modeling rett syndrome using TALEN-edited MECP2 Mutant cynomolgus monkeys. Cell 2017;169:945-55.e10.
57. Tu Z, Zhao H, Li B, et al. CRISPR/Cas9-mediated disruption of SHANK3 in monkey leads to drug-treatable autism-like symptoms. Hum Mol Genet 2019;28:561-71.
58. Haznedar MM, Buchsbaum MS, Hazlett EA, LiCalzi EM, Cartwright C, Hollander E. Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. Am J Psychiatry 2006;163:1252-63.
59. Buchsbaum MS, Hollander E, Haznedar MM, et al. Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study. Int J Neuropsychopharmacol 2001;4:119-25.
60. Durand CM, Betancur C, Boeckers TM, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007;39:25-7.
61. Richards C, Powis L, Moss J, Stinton C, Nelson L, Oliver C. Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder. J Neurodev Disord 2017;9:37.
62. Phelan K, McDermid HE. The 22q13.3 deletion syndrome (phelan-mcdermid syndrome). Mol Syndromol 2012;2:186-201.
63. Wu L, Mei S, Yu S, Han S, Zhang YQ. Shank3 mutations enhance early neural responses to deviant tones in dogs. Cereb Cortex 2023;33:10546-57.
64. Zhao L, Li Y, Kou X, et al. Stem cells from human exfoliated deciduous teeth ameliorate autistic-like behaviors of SHANK3 mutant beagle dogs. Stem Cells Transl Med 2022;11:778-89.
65. Yang W, Guo X, Tu Z, et al. PINK1 kinase dysfunction triggers neurodegeneration in the primate brain without impacting mitochondrial homeostasis. Protein Cell 2022;13:26-46.
66. Kitada T, Pisani A, Porter DR, et al. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci U S A 2007;104:11441-6.
67. Akundi RS, Huang Z, Eason J, et al. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice. PLoS One 2011;6:e16038.
68. Xiong H, Wang D, Chen L, et al. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest 2009;119:650-60.
69. Yang W, Liu Y, Tu Z, et al. CRISPR/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys. Cell Res 2019;29:334-6.
